Elicio Therapeutics
MA - Boston
Biotechnology1 H-1B visas (FY2023)Focus: HPV-induced cancer treatments
Elicio Therapeutics is a life sciences company focused on HPV-induced cancer treatments.
Oncology
Open Jobs
2
Pipeline & Clinical Trials
ELI-002 7P
Pancreatic Ductal AdenocarcinomaClinical Trials (1)
NCT07083479Expanded Access Protocol of ELI-002-102 in Subjects With KRAS/NRAS Mutated Pancreatic Ductal Adenocarcinoma
N/AELI-002 2P
Minimal Residual DiseaseClinical Trials (1)
NCT04853017A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors
Phase 1ELI-002 7P
Pancreatic Ductal AdenocarcinomaClinical Trials (1)
NCT05726864A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors
Phase 1/2Open Jobs (2)
Interview Prep Quick Facts
Portfolio: 3 clinical trials
H-1B (2023): 1 approval
Open Roles: 2 active jobs
Hiring Trend
Stable
2
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles
Visa Sponsorship
Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate
Source: USCIS H-1B Employer Data Hub